Palvella Therapeutics (PVLA) Receivables (2016 - 2024)
Historic Receivables for Palvella Therapeutics (PVLA) over the last 11 years, with Q3 2024 value amounting to $1.0 million.
- Palvella Therapeutics' Receivables fell 373.21% to $1.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.0 million, marking a year-over-year decrease of 373.21%. This contributed to the annual value of $3.1 million for FY2023, which is 7031.47% down from last year.
- Palvella Therapeutics' Receivables amounted to $1.0 million in Q3 2024, which was down 373.21% from $4.5 million recorded in Q2 2024.
- In the past 5 years, Palvella Therapeutics' Receivables ranged from a high of $17.0 million in Q2 2021 and a low of $829000.0 during Q3 2022
- In the last 5 years, Palvella Therapeutics' Receivables had a median value of $3.1 million in 2023 and averaged $5.1 million.
- In the last 5 years, Palvella Therapeutics' Receivables plummeted by 9256.47% in 2022 and then soared by 37626.05% in 2024.
- Palvella Therapeutics' Receivables (Quarter) stood at $1.7 million in 2020, then soared by 94.2% to $3.3 million in 2021, then surged by 219.38% to $10.6 million in 2022, then crashed by 70.31% to $3.1 million in 2023, then plummeted by 67.97% to $1.0 million in 2024.
- Its Receivables was $1.0 million in Q3 2024, compared to $4.5 million in Q2 2024 and $4.9 million in Q1 2024.